(Q2)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|
Assets | ||||
Current assets | ||||
Cash, cash equivalents and short term investments | --198.34K | -80.53%6.38K | --32.77K | --0 |
-Cash and cash equivalents | --198.34K | -80.53%6.38K | --32.77K | --0 |
Total current assets | --566.01K | 12.19%46.35K | 1,763.46%41.31K | --2.22K |
Non current assets | ||||
-Goodwill | --253.87K | --382.73K | --0 | ---- |
Due from related parties non current | --260.38K | ---- | ---- | ---- |
Regulatory assets | --13.32K | --13.1K | --0 | ---- |
Non current deferred assets | --260.38K | ---- | ---- | ---- |
Total assets | --13.32K | --13.1K | --0 | ---- |
Liabilities | ||||
Current liabilities | ||||
Current debt and capital lease obligation | --59.73K | ---- | ---- | --522 |
-Current debt | --25K | ---- | ---- | --522 |
-Current capital lease obligation | --34.73K | ---- | ---- | ---- |
-accounts payable | --529.11K | 2,153.39%404.78K | -17.38%17.96K | --21.74K |
-Total tax payable | --13.56K | --13.34K | --0 | --5.3K |
-Due to related parties current | --1.05M | --506.2K | --0 | ---- |
Current deferred liabilities | --926.67K | 5.10%289.3K | 3,379.64%275.27K | --7.91K |
Current liabilities | --2.56M | 309.32%1.2M | 871.79%293.24K | --30.18K |
Non current liabilities | ||||
Total non current liabilities | --2.58M | 313.87%1.21M | 726.56%293.24K | --35.48K |
Shareholders'equity | ||||
Share capital | --20 | 0.00%20 | 0.00%20 | --20 |
-common stock | --20 | 0.00%20 | 0.00%20 | --20 |
Gains losses not affecting retained earnings | ---13.67K | -36.49%8.33K | 1,753.25%13.12K | --708 |
Other equity interest | --35.11K | ---- | ---- | ---- |
Total equity | --1.08M | 938.61%429.08K | 1,763.46%41.31K | --2.22K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.